Search
Selected Filter
Displaying 11–20 of 285 research results
-
Recap of Retinal Disease News from the 2022 Meeting of the American Academy of Ophthalmology
Eye On the Cure Research NewsReports on emerging therapies for dry age-related macular degeneration (geographic atrophy), Stargardt disease, and X-linked retinitis pigmentosa are included
-
Atsena’s LCA-GUCY2D Gene Therapy Improves Vision in Phase 1/2 Clinical Trial
Eye On the Cure Research NewsThe company is planning to move the emerging treatment into a pivotal trial
-
Eye On the Cure Research News
Small data sets present challenges for developing rare disease AI tools
-
Iveric Bio’s Zimura for Advanced Dry AMD Meets Endpoint in Second Phase 3 Clinical Trial
Eye On the Cure Research NewsThe company plans to seek FDA approval for the emerging therapy in first quarter of 2023
-
Belite Bio Launching Phase 3 Clinical Trial for Stargardt Disease Drug
Eye On the Cure Research NewsThe company’s drug is designed to reduce accumulation of toxins that cause vision loss.
-
ProQR Seeking to Partner Ophthalmic Programs
Eye On the Cure Research NewsThe company is halting its clinical programs for LCA10 and USH2A as it seeks a new partner
-
Eye On the Cure Research News
Funding for the new grants was made possible by Foundation’s strong donor base and philanthropic partners
-
Eye On the Cure Research News
The emerging therapy is designed to restore vision for people with advanced retinal degenerative diseases
-
Apellis’ Treatment for Advanced Dry AMD to Receive Priority Review from FDA
Eye On the Cure Research NewsThere are currently no FDA-approved therapies for geographic atrophy (GA), the advanced form of dry AMD.
-
Endogena Launches Clinical Trial of Therapy to Activate Stem Cells in RP Patients’ Retinas
Eye On the Cure Research NewsThe emerging treatment is gene-agnostic.
.png)
.png)
